NCT04783402 is a NA clinical trial of e-OTCAT program in Breast Neoplasms, sponsored by Universidad de Granada.

Who is sponsoring NCT04783402?

NCT04783402 is sponsored by Universidad de Granada.

What drugs are being tested in NCT04783402?

Interventions in NCT04783402: e-OTCAT program, Educational handbook and standard care.

What condition does NCT04783402 study?

NCT04783402 studies Breast Neoplasms.

Is NCT04783402 still recruiting?

NCT04783402 is currently status unknown. Last updated 11 December 2023.

Last reviewed 2023-12-11 · How we verify

NCT04783402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telehealth Program to Prevent Cancer and Chemotherapy-related Cognitive Impairment.

Status unknown NA Last updated 11 December 2023

What this trial tests

NA trial testing e-OTCAT program in Breast Neoplasms in 98 participants. Status unknown.

Timeline

31 October 2020

Primary endpoint
30 December 2024

30 December 2024

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	98
Start date	31 October 2020
Primary completion	30 December 2024
Estimated completion	30 December 2024
Sites	1 location across Spain

Drugs / interventions tested

e-OTCAT program
Educational handbook and standard care

Conditions studied

Breast Neoplasms — all drugs for Breast Neoplasms →

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 18 to 70, female only, with Breast Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present randomized controlled trial has the main objective to study the effects of a videoconferenced occupational therapy program in preventing cancer and chemotherapy-related cognitive impairment and other health outcomes, as well as in improving quality of live and occupational performance of women undergoing chemotherapy for breast cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Telehealth-Based Cognitive-Adaptive Training (e-OTCAT) to Prevent Cancer and Chemotherapy-Related Cognitive Impairment in Women with Breast Cancer: Protocol for a Randomized Controlled Trial.
González-Santos Á, Lopez-Garzon M, Sánchez-Salado C, Postigo-Martin P, et al · · 2022 · cited 5× · PMID 35742400 · DOI 10.3390/ijerph19127147

Verify or expand the search:

Other recruiting trials for Breast Neoplasms

Currently open trials in the same condition.

NCT07214532 — Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer · NA · recruiting
NCT07500428 — Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models · recruiting
NCT07581834 — Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multic · Phase 2 · recruiting
NCT07222215 — PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA) · Phase 2 · recruiting
NCT07465393 — Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors · NA · recruiting

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04783402 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 11 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04783402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing